Lacritin and Heparanase Levels in Human Tears After Laser Refractive Surgery
1 other identifier
observational
196
1 country
1
Brief Summary
The purpose of this study is to measure tear lacritin and heparanase levels before and following surgery using a minimal risk procedure to collect tears from patients undergoing PRK or LASIK.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2010
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedFirst Submitted
Initial submission to the registry
January 13, 2010
CompletedFirst Posted
Study publicly available on registry
January 14, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2017
CompletedFebruary 7, 2018
February 1, 2018
7.8 years
January 13, 2010
February 6, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The primary outcome measure is tear lacritin levels pre- and post-surgery.
pre and standard visits up to 6 months post-surgery
Secondary Outcomes (1)
The secondary outcome is tear heparanase levels pre- and post-surgery
pre- and at standard visits up to 6 months post-surgery
Study Arms (2)
PRK
Those patients undergoing photorefractive keratectomy
LASIK
Those undergoing Laser-assisted insitu keratomileusis
Interventions
Eligibility Criteria
Active duty military aged 21 to 55 with myopia up to -10.00 diopters eligible for care at Walter Reed Army Medical Center.
You may qualify if:
- Active duty US Army Soldiers eligible for care at FBCH
- Undergoing PRK or LASIK
- Male or female, of any race, and at least 21 years old and not older than 55 years old at the time of the tear collection. The lower age limit of 21 years is intended to ensure documentation of refractive stability.
- Appropriately aged individuals who report that their eyes are "normal" and who have no active eye illness as determined by the principal investigator or sub-investigator.
- Ability and willingness to understand and provide informed consent to participate in this study.
- Up to -10.00 diopters of myopia.
- Subject must expect to be located in the greater Washington DC area for a 12 month period post-operatively.
- Consent of the subject's command (active duty) to participate in the study.
- Access to transportation to meet follow-up requirements.
You may not qualify if:
- Any reason to be excluded for PRK or LASIK
- Female subjects who are pregnant, breast-feeding or intend to become pregnant during the study. Female subjects will be given a urine pregnancy test prior to participating in the study to rule out pregnancy. \[Pregnancy and breastfeeding are contraindications to refractive surgery in general, including PRK, whether participating in this study or not\]
- Patients with known sensitivity or inappropriate responsiveness to any of the medications used in the post-operative course.
- Any physical or mental impairment that would preclude participation in any of the examinations.
- Anterior basement membrane dystrophy
- History of recurrent epithelial erosion
- Significant dry eye (symptomatic with Schirmer \<5mm at 5 minutes)
- Other corneal epithelial disorder or healing abnormality
- Individuals with any infectious or inflammatory ocular conditions (e.g. have "pink eye" or uveitis).
- Individuals diagnosed with dry eye or other ocular surface condition, including but not restricted to neurotropic keratitis, anterior basement membrane dystrophy, and recurrent corneal erosions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fort Belvoir Community Hospitallead
- James Madison Universitycollaborator
- University of Virginiacollaborator
Study Sites (1)
Fort Belvoir Community Hospital
Fort Belvoir, Virginia, 22060, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kraig S. Bower, MD
The Wilmer Eye Institute, Johns Hopkins University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- FED
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Warfighter Refractive Eye Surgery Program and Research Center at FT Belvoir
Study Record Dates
First Submitted
January 13, 2010
First Posted
January 14, 2010
Study Start
January 1, 2010
Primary Completion
November 1, 2017
Study Completion
November 1, 2017
Last Updated
February 7, 2018
Record last verified: 2018-02